HOME >> BIOLOGY >> NEWS
Combination therapy dramatically improves function after spinal cord injury in rats

A combination therapy using transplanted cells plus two experimental drugs significantly improves function in paralyzed rats, a new study shows. The results suggest that a similar therapy may be useful in humans with spinal cord injury. The study was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and appears in the June 2004 issue of Nature Medicine.*

About 10,000 people in the United States suffer spinal cord injuries each year. Studies in animals during the past decade have shown that supporting cells from nerves outside the brain and spinal cord, called Schwann cells, can be used to make a "bridge" across the damaged spinal cord that encourages nerve fibers to regrow. Other research has suggested that a substance called cyclic AMP (cyclic adenosine monophosphate) can turn on growth factor genes in nerve cells, stimulating growth and helping to overcome signals that normally inhibit regeneration. This study is the first to try a combination of the two approaches in an animal model of spinal cord injury.

In the new study, Mary Bartlett Bunge, Ph.D., Damien Pearse, Ph.D., and colleagues at the Miami Project to Cure Paralysis at the University of Miami School of Medicine, found that spinal cord injury triggers a loss of cAMP in the spinal cord and in some parts of the brain. They then transplanted Schwann cells into the spinal cords of rats in a way that bridged the damaged area. The researchers also gave the rats a form of cAMP and a drug called rolipram, which prevents cAMP from being broken down.

Treatment with the triple-combination therapy preserved and even elevated cAMP levels in nerve cells after injury. It also preserved many of the myelinated nerve fibers in treated animals, compared to untreated rats and those that did not receive the triple combination, the researchers found. Myelin is a fatty substance that insulates the nerve fibers and
'"/>

Contact: Natalie Frazin or Paul Girolami
301-496-5924
NIH/National Institute of Neurological Disorders and Stroke
23-May-2004


Page: 1 2

Related biology news :

1. Combination of gene therapy and gene silencing prevents neurodegenerative disease
2. Combination therapy drives cancer into remission
3. Combination drug therapy drastically reduces multiple coronary heart disease risk factors
4. Combination therapy improves anthrax survival
5. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
6. Combination Therapy For Brain Tumors Holds Promise For Longer Survival After Surgery
7. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
8. Dangerous Chemical Combination Presents Possible Scenario For Gulf War Illnesses
9. Targeted therapy knocks out pediatric brain cancer in mice
10. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
11. Columbia research to examine gene influence on severity of peridontal disease, therapy response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2018)... ... 25, 2018 , ... Maire Mayne, an evidence-based energy healer, ... to reduce inflammation and autoimmune disorders and improve overall immune response. , The ... The following data was reported:,     Over 180% increase in ...
(Date:8/23/2018)... ... August 21, 2018 , ... CRISPR-Cas9 gene editing strategies have ... for the robust functional interrogation of complex biological processes. Gene editing in primary ... the study of the autoimmunity, the understanding of host-pathogen dynamics that drive HIV ...
(Date:8/23/2018)... ... ... Lajollacooks4u is proud to have hosted a variety of groups this year – both new ... Qualcomm, Hewlett Packard, Sequenom and more, have all visited the La Jolla-based venue time and ... the reason clientele return is due to Lajollacooks4u’s signature team-building format, a way for teams ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... , ... August 28, 2018 , ... USDM Life ... the life sciences and healthcare industries, announces that Manu Vohra will deliver a presentation ... , What: “How to Implement Box for GxP in 30 Days” , When: ...
(Date:8/23/2018)... ... 23, 2018 , ... Visikol began its journey in late 2012 ... from advisors, mentors, the Rutgers Technology Transfer team and Foundation Venture Capital Group, Visikol ... to a successful biotech company has been a circuitous path but was due in ...
(Date:8/17/2018)... ... 16, 2018 , ... KCAS Bioanalytical and Biomarker Services, a ... their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of BioPharma. , ... that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. Dr. Dufield ...
(Date:8/14/2018)... ... August 14, 2018 , ... Buprenorphine (BUP) is a ... is often prescribed as a sublingual co-formulation with the opioid antagonist naloxone (NXO) ... will learn from a review of the pharmacokinetics of BUP, NBP, and NXO ...
Breaking Biology Technology:
Cached News: